Replies to post #19210 on NanoViricides Inc. (NNVC)

[cabel]

WE were anticipating that we were further along than this.

It is still good,...just more time before we see a deal than we were hoping for.

[Ubertino]

Will that independent research institute carry our cides through the FDA as well? I say it in the plural while only the eyes are invoved - two viruses - HSV and EKC.

Seems like a natural to me.

Serious stuff today.

--The pharmaceutical company initially plans to evaluate NanoViricides’s drug candidate for effectiveness against external ophthalmic diseases caused by two different virus types, namely herpes simplex virus (HSV) and adenovirus.--

'Initially ' - it's only just the START! And 'eyes' to start - might the entire range of viruses follow?

I note that what with big pharmas taking over little eye centric pharmas the big pharma may well decide, all in due course, that they desire to use our other cides for ALL viral diseases, not just for eyes. So what got our foot in the door with the little eye pharma (now part of a huge big pharma) may lead to getting not only our foot in the door of the big pharma but everything else, too.

Serious stuff.